CDC Website CDC Website

To Join the NPIN community or

Home » A New Tool to Diagnose Tuberculosis: The Xpert MTB/RIF Assay

Due to the evolving COVID-19 situation, NPIN may not have the most up-to-date organization changes to services or hours. Please call the organization or visit their website to find out about any changes. This site does not have information about where to get tested for COVID-19. For COVID-19 information please visit: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Debido a la rápida evolución de la situación con respecto al COVID-19, NPIN podría no tener la información mas actualizada de los servicios u horas de las organizaciones. Por favor llame o visite la página web de la organización para conocer los cambios. Este sitio no tiene información sobre donde hacerse la prueba del COVID-19. Para información sobre el COVID-19 por favor visite: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

A New Tool to Diagnose Tuberculosis: The Xpert MTB/RIF Assay

Centers for Disease Control and Prevention, National Center for HIV Viral Hepatitis STD and TB Prevention
Thumbnail image of A New Tool to Diagnose Tuberculosis: The Xpert MTB/RIF Assay
This information sheet discusses the Xpert MTB/RIF Assay for diagnosing TB. It explains that the new test is a nucleic acid amplification test that diagnoses TB in less than 2 hours and can also determine resistance to rifampin, one of the drugs used to treat TB. The information sheet describes how the Xpert MTB/RIF assay works, its advantages, how the results should be interpreted, what it means if RIF resistance is detected, not detected, or is indeterminate. Addresses for additional information are provided.
Disease
Topics/Subjects
Year of Publication
2014
Physical Description
2 p. col.

Last Updated Date: 

8/19/15

Publication ID: 

35762